ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

VTRS Viatris Inc

11.57
-0.21 (-1.78%)
2024年5月1日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Viatris Inc VTRS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.21 -1.78% 11.57 08:00:00
始値 安値 高値 終値 前日終値
11.74 11.57 11.75 11.57 11.78
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1705:30PRNUSViatris to Report First Quarter 2024 Financial Results on..
2024/4/1521:00PRNUSViatris Appoints Corinne Le Goff as Chief Commercial Officer
2024/4/1519:59PRNCAViatris Announces Launch of First Bioequivalent Generic..
2024/4/0119:59PRNUSViatris Announces the Launch of RYZUMVl™ (Phentolamine..
2024/3/2719:59PRNUSViatris Hosts R&D Event Focusing on its Collaboration with..
2024/3/0610:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0610:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0610:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0609:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0609:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0609:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/3/0508:11EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2821:39EDGAR2Form 8-K - Current report
2024/2/2820:30PRNUSViatris Reports Fourth-Quarter and Full-Year 2023 Financial..
2024/2/2815:00PRNUSViatris and Idorsia Enter Into Significant Global Research..
2024/2/2408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1708:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1607:18EDGAR2Form 144 - Report of proposed sale of securities
2024/2/0520:59PRNUSViatris to Announce Fourth Quarter and Full-Year 2023..
2024/1/3106:40EDGAR2Form 8-K/A - Current report: [Amend]
2024/1/1920:56PRNUSViatris recognised as a Top Employer 2024 in the UK for the..
2024/1/0608:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0510:28EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2206:05PRNUSViatris to Participate in 42nd Annual J.P. Morgan Healthcare..
2023/12/1608:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1607:04EDGAR2Form 8-K/A - Current report: [Amend]
2023/12/1607:00EDGAR2Form 8-K - Current report
2023/12/1606:45PRNUSViatris Continues its Preparations for Phase 2 of its..
2023/12/1606:14EDGAR2Form 8-K - Current report
2023/12/1606:12EDGAR2Form 8-K - Current report
2023/12/1606:05PRNUSViatris Shareholders Re-elect All Nominated Directors and..
2023/12/1507:31EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2508:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2506:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/11/2503:02EDGAR2Form 144 - Report of proposed sale of securities
2023/11/1422:00PRNUSViatris to Participate in the Jefferies London Healthcare..
2023/11/1322:00PRNUSViatris and Theravance Biopharma Announce Positive Top-Line..
2023/11/0806:39EDGAR2Form 8-K - Current report
2023/11/0806:02PRNUSViatris Reports Strong Financial and Operational Results for..
2023/11/0405:36EDGAR2Form ARS - Annual Report to Security Holders
2023/11/0405:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/11/0405:31EDGAR2Form DEF 14A - Other definitive proxy statements
2023/10/3022:00PRNUSViatris to Host Webinar: The Power of Partnership to Address..
2023/10/2505:32EDGAR2Form 8-K - Current report
2023/10/2505:30EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/10/2322:00PRNUSViatris Named to Forbes' Annual List of the World's Best..
2023/10/2106:18EDGAR2Form 8-K - Current report
2023/10/2106:00PRNUSRajiv Malik to Retire as President of Viatris Effective..
2023/10/1821:00PRNUSViatris Named to 3BL's 100 Best Corporate Citizens of 2023..
2023/10/1022:29PRNUSViatris to Release Third Quarter 2023 Financial Results on..

最近閲覧した銘柄

Delayed Upgrade Clock